Brazil is developing lab-grown donkey collagen to counter a global decline in donkey populations driven by rising demand for China’s traditional anti-ageing medicine, ejiao. Through the effort, scientists are aiming to deliver a scalable alternative by 2027 that could reduce slaughter and stabilise the species.